15 research outputs found
Componente Práctico para la obtención del Título de Ingeniera en Administración de Empresas y Negocios
La creación del presente manual de procesos, tiene como finalidad ser una herramienta que contribuya al desarrollo de las actividades, que se realizan en el proceso de elaboración de certificados, con el objetivo de ser una guía metodológica y de consulta tanto para el personal nuevo como para el personal que ya se encuentre realizando esta actividad, de la misma forma ayudara a tener un documento en el cual las personas que por motivos de cambio de funciones, o de rotación de personal se involucre en el proceso de elaboración de certificados dentro de la institución. Que en la ausencia del personal encargado de elaborar los certificados, se pueda encontrar un documento que le enseñe: el cómo, el por qué y cuándo realizar las tareas con la descripción de cada una de ellas, dentro del proceso de la elaboración de los certificados, mediante la revisión del manual de procedimientos, donde pueda informarse e instruirse correctamente sobre la ejecución de la operación y que le facilite el desenvolvimiento en las actividades que le fueron delegadas, de tal manera que se llegara a cumplir los objetivos y las metas propuestas.
La mejora el proceso de entrega de información hidrometeorológica, al usuario externo, se refleja por medio de la calidad de sus servicios o productos. Entre las áreas implicadas se realiza la implementación de un documento de control que se utilice para facilitar el seguimiento interno en el que se desarrolla determinada actividad sobre la información que fue solicitada, y se llegue a cumplir con la entrega de los certificados a las entidades públicas o privadas, entre otras. Al tener establecido las actividades de forma clara se efectúa la mejora del proceso en la elaboración y entrega de los certificados
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia
A 50-year-old male with chronic lymphocytic leukemia (CLL) was treated with fludarabine, cyclophosphamide and rituximab, which produced a complete remission. Eight months after the last dose of rituximab he had visual disturbance, diminished muscular strength in the right arm and vesicular-papular lesions in the left ophthalmic branch region of the V cranial nerve. These were initially interpreted as herpes virus encephalopathy (HVE), but brain magnetic resonance imaging (MRI) showed evidence of demyelination consistent with progressive multifocal leukoencephalopathy (PML). Cerebrospinal fluid (CSF) analysis was negative for varicella zoster virus (VZV) and John Cunningham virus (JCV) DNA. The clinical suggestion of PML prompted us to perform a brain biopsy and to start treatment with mefloquine. In the brain biopsy, histopathological features of demyelination were described and the polymerase chain reaction (PCR) identified JCV, confirming the diagnosis of PML. Treatment with mefloquine (250 mg/week) and dexamethasone (4 mg/day) was started and maintained for 6 months. A year later there was an almost complete resolution of the MRI lesions and the patient achieved a stable clinical state with persisting motor impairment and severe epilepsy. The patient is alive 38 months after diagnosis of PML, which is the longest known survival to date.Supported by grants from the Fondo de Investigaciones Sanitarias -
Ministerio de Ciencia e Innovación (PI12/1832), Plan Nacional of I + D + I co-financed by ISCIII-Subdirección General de Evaluación and Fondo Europeo de Desarrollo Regional (FEDER). HG has a grant from Fundación BBVA - Fundación Carolina.S
Prevalencia de genotipos del virus del papiloma humano de alto riesgo no vacunables dentro del programa de Detección Precoz de Cáncer de Cérvix en Cantabria
Estimar la prevalencia de infección por genotipos del virus del papiloma humano(VPH) de alto riesgo no vacunables.Dise˜no: Estudio descriptivo transversal.Emplazamiento: Siete centros de salud de Cantabria seleccionados aleatoriamente.Participantes: Se incluyó a todas las mujeres con una citología vaginal valorable (n = 3.359)entre 2010-2011.Mediciones principales: Se recogieron diagnóstico citológico, resultado de PCR y método anti-conceptivo. Los resultados de las citologías se clasificaron con el sistema Bethesda. Para latipificación de VPH según el riesgo oncogénico se utilizó la clasificación de Mu˜noz et al. Seestimaron proporciones y odds ratio (OR) con sus correspondientes intervalos de confianza al95% (IC95%).Resultados: La prevalencia de infección por VPH fue del 2,71% (IC95%: 2,15-3,27). La prevalen-cia de genotipos de VPH de alto riesgo oncogénico fue del 2,26%; (IC95%: 1,75-2,78). El genotipomás frecuente fue el 16 (28,89%). Más de la mitad de las mujeres fueron positivas para algúngenotipo de alto riesgo no vacunable: 51 (18,89%) o 58 (13,33%) o 68 (12,22%) o 31 (11,11%). Enel 23,33% de las mujeres coexistieron al menos 2 genotipos de alto riesgo no vacunables. Lasmujeres más jóvenes (≤ 30 a˜nos) tuvieron 2 veces más riesgo de infección por cualquier VPH:OR 2,01; (IC95%: 1,02-3,96); y 2 veces más probabilidad de usar anticonceptivos hormonalesfrente al preservativo: OR 2,09; (IC95%: 1,64-2,67).Conclusiones: Atendiendo al alto porcentaje de VPH de alto riesgo oncogénico no vacunable,habría que replantear la estrategia de prevención en la población, que podría tener una falsasensación de protección
Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
Aim To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19 have a worse prognosis than non-healthcare workers (NHCW). Methods Observational cohort study based on the SEMI-COVID-19 Registry, a nationwide registry that collects sociodemographic, clinical, laboratory, and treatment data on patients hospitalised with COVID-19 in Spain. Patients aged 20-65 years were selected. A multivariate logistic regression model was performed to identify factors associated with mortality. Results As of 22 May 2020, 4393 patients were included, of whom 419 (9.5%) were HCW. Median (interquartile range) age of HCW was 52 (15) years and 62.4% were women. Prevalence of comorbidities and severe radiological findings upon admission were less frequent in HCW. There were no difference in need of respiratory support and admission to intensive care unit, but occurrence of sepsis and in-hospital mortality was lower in HCW (1.7% vs. 3.9%; p = 0.024 and 0.7% vs. 4.8%; p<0.001 respectively). Age, male sex and comorbidity, were independently associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.211, 95%CI 0.067-0.667, p = 0.008). 30-days survival was higher in HCW (0.968 vs. 0.851 p<0.001). Conclusions Hospitalized COVID-19 HCW had fewer comorbidities and a better prognosis than NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not carry more clinical severity nor mortality
Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management
Background: Immunodeficiencies (ID), in particular primary immunodeficiencies (PID), are often associated with haematological manifestations, such as peripheral cytopenias or lymphoproliferative syndromes. Early diagnosis and management have significant prognostic implications. Secondary immunodeficiencies (SID) may also be induced by oncohaematological diseases and their treatments. Haematologists and oncologists must therefore be aware of the association between blood disorders and cancer and ID, and be prepared to offer their patients appropriate treatment without delay. Our aim was to define the warning signs of primary and secondary IDs in paediatric and adult patients with oncohaematological manifestations.Methods: A multidisciplinary group of six experts (2 haematologists, 2 immunologists, and 2 paediatricians specializing in ID) conducted a literature review and prepared a document based on agreements reached an in-person meeting. An external group of 44 IDs specialists from all over Spain assessed the document and were consulted regarding their level of agreement.Results: This document identifies the haematological and extra-haematological diseases that should prompt a suspicion of PIDs in adults and children, in both primary care and haematology and oncology departments. Cytopenia and certain lymphoproliferative disorders are key diagnostic pointers. The diagnosis must be based on a detailed clinical history, physical exploration, complete blood count and standard laboratory tests. The immunological and haematological tests included in the diagnostic process will depend on the care level. Patients who are candidates for immunoglobulin replacement therapy must be carefully selected, and treatment should be offered as soon as possible to avoid the development of complications. Finally, this document recommends procedures for monitoring these patients.Conclusions: This document combines scientific evidence with the opinion of a broad panel of experts, and emphasizes the importance of an early diagnosis and treatment to avoid complications. The resulting document is a useful tool for primary care physicians and specialists who see both adult and paediatric patients with oncohaematological diseases
Efecto de los polimorfismos factor V. Leiden, G20210A del gen de la protrombina y polimorfismos C677T y A1298C del gen de la metilen tetrahidrofolato reductasa en pacientes con enfermedad cerebrovascular isquémica
Tesis doctoral inédita leída en la Universidad Autónoma de Madrid. Facultad de Medicina. Departamento de Medicina. Fecha de lectura: 28 de Septiembre de 200
Análisis cuantitativo del impacto de la devolución del IVA petrolero en las finanzas públicas ecuatorianas
El objetivo del presente trabajo de investigación es cuantificar el impacto del monto de la devolución del impuesto al valor agregado a las empresas petroleras dentro del presupuesto general del estado. El estudio se desarrollará a través de cuatro capítulos, en los mismos que se tratarán distintos temas como el análisis del sector petrolero ecuatoriano, el presupuesto general del estado, la política tributaria.....
Evaluation of thrombophylic states in myeloma patients receiving thalidomide: a reasonable doubt
Herpesvirus in the oral cavity of children with leukaemia and its impact on the oral bacterial community profile
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
The Grupo Español de Linfomas y Trasplantes de Médula Ósea International Prognostic Index (GELTAMO-IPI) stratifies four risk groups in diffuse large B cell lymphoma (DLBCL) patients treated with immunochaemotherapy: low (LR), low-intermediate (LIR), high-intermediate (HIR), and high (HR). The present study explores the effect of GELTAMO-IPI in the DLBCL subtypes defined by the immunohistochaemistry-based Hans algorithm, Germinal Centre B (GCB) and non-GCB. A multivariate Cox regression model including GELTAMO-IPI risk groups, cell of origin (COO) subtypes and their product was developed to evaluate interaction between the two variables. The COO subtype was available in 839 patients (380 GCB; 459 non-GCB) and both the GELTAMO-IPI and the COO subtype in 780 (353 GCB; 427 non-GCB). There were no differences in 5-year overall survival (OS) between the two subtypes. The Cox model revealed interaction between the GELTAMO-IPI risk groups and the COO subtypes (P = 0·005), indicating that GELTAMO-IPI has a different effect in the two subtypes. Three risk groups were stratified in both COO subtypes: in the GCB subtype, LR, LIR and the combined HIR+HR had 5-year OS of 100%, 75% and 52%, respectively. In the non-GCB subtype, LR, the combined LIR+HIR and HR had a 5-year OS of, 97%, 82% and 35% respectively. GELTAMO-IPI identifies a genuine poor outcome group of patients in the DLBCL non-GCB subtype